Evaluation of the long-term safety and tolerability of oral atogepant 60 mg once daily for preventive treatment of migraine: a phase 3, 40-week, multi-center extension to the advance trial

被引：0

作者：

Klein, B. ^{[1
]}

Miceli, R. ^{[2
]}

Severt, L. ^{[2
]}

McAllister, P. ^{[3
]}

Mechtler, L. ^{[4
]}

McVige, J. ^{[4
]}

Diamond, M. ^{[5
]}

Marmura, M. J. ^{[6
]}

Guo, H. ^{[2
]}

Finnegan, M. ^{[2
]}

Trugman, J. M. ^{[2
]}

机构：

[1] Abington Neurol Associates Ltd, Abington, PA USA

[2] AbbVie, Madison, NJ USA

[3] New England Inst Neurol & Headache, Stamford, CT USA

[4] DENT Neurol Inst, Amherst, NY USA

[5] Diamond Headache Clin Ltd, Chicago, IL USA

[6] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA

来源：

CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

AL077

引用

页码：235 / 235

页数：1

共 34 条

[31] Long-Term (104-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial and Open-Label Extension
Mease, Philip
Adebajo, Adewale O.
Gladman, Dafna D.
Gomez-Reino, Juan J.
Hall, Stephan
Kavanaugh, Arthur
Lespessailles, Eric
Schett, Georg A.
Shah, Kamal
Stevens, Randall M.
Teng, Lichen
Wollenhaupt, Juergen
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S690 - S691
[32] DISEASE ACTIVITY AND SAFETY DURING LONG-TERM (104-WEEK) TREATMENT WITH APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 3)
Edwards, C.
Blanco, F.
Crowley, J.
Hu, C.
Shah, K.
Birbara, C.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 348 - 349
[33] Disease Activity and Safety during Long-Term (104-Week) Treatment with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension
Edwards, Christopher J.
Blanco, Francisco J.
Crowley, Jeffrey
Hu, ChiaChi
Shah, Kamal
Birbara, Charles A.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[34] NUCLEOS(T)IDE ANALOGUES IN THE TREATMENT OF LONG-TERM PROGNOSIS IN PATIENTS WITH HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA AFTER RADICAL SURGERY: INTERIM ANALYSIS OF THE PHASE 3 MULTI-CENTER PROSPECTIVE TRIAL
Zhou, Zhongguo
Wu, Tianqing
Huang, Li
Qiu, Chunhui
Li, Guolin
Hu, Dandan
Zhang, Yaojun
Xu, Li
Chen, Minshan
HEPATOLOGY, 2024, 80

← 1 2 3 4 →